canakinumab
novartis
['lcsm,(-blcsm)', 'canakinumab', 'canopya']
#esmo22 canopya from drgaron- learning from a negative study: dfs not improved with canakinumab over pbo given data from plenary, il-1 blocking might work in primary prevention but not in preventing recurrence? #some #lcsm 
#MedicalOncologist MSc Transl Res Univ Paris Sud   #LungCancer biology, immunotherapy, clinical trials #LCSM @myESMO faculty #OncoAlert   live to give